Biography: Katherine Slain, DO
- Program Director, Pediatric Critical Care Medicine, UH Rainbow Babies and Children's Hospital
- Assistant Professor of Pediatrics, CWRU School of Medicine
- Associate Professor of Pediatrics, CWRU School of Medicine
Certifications & Memberships
- Pediatric Critical Care Medicine - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - Uh Case Medical Center (2013 - 2016)
Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - Akron Children's Hospital (2012 - 2013)
Residency | Pediatrics
Pediatrics - Akron Children's Hospital (2009 - 2012)
Midwestern University Chicago College Of Osteopathic Medicine (2009)
University Of North Carolina At Chapel Hill (2001)
After completing her clinical fellowship in critical care at University Hospitals Rainbow Babies & Children’s, Katherine N. Slain, DO, joined University Hospitals and Case Western Reserve University in the Department of Pediatrics in July 2016, where she works as a pediatric intensivist
Dr. Slain completed her residency in pediatrics at Akron Children’s Hospital, where she received recognition for her clinical, teaching and research accomplishments including the Annual Resident Teaching Award, the Nicholas Libertin Award and the James G. Kramer Research Award. Dr. Slain served as the Chief Resident at completion of her training. She continued her clinical training in pediatric critical care medicine at UH Rainbow.
Dr. Slain is an active member of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) network, where she serves on the Scientific Committee, and as founding Co-Chair of the Social Determinants of Health Subgroup. She has authored over thirty peer-reviewed manuscripts and several textbook chapters. She has given grand rounds locally and nationally, and been an invited speaker at multiple national conferences including the Society for Pediatric Sedation conference, the Improving Pediatric Sepsis Outcomes workshop, and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) conference.
Related Blog Articles
The star athlete, called Z by his friends and family, collapsed in the locker room at the start of halftime.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Katherine Slain did not disclose any Outside Relationships with Industry.